A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
ConclusionThis newly developed TP scoring system has the potential to be a useful tool in identifying ideal candidates of TACE and predicting OS with favorable performance and discrimination. However, further external validation is needed to confirm its effectiveness.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Children | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Training | Universities & Medical Training | Urology & Nephrology